IKK2 inhibition attenuates laser-induced choroidal neovascularization

Area of Science:

• Ophthalmology
• Molecular Biology
• Immunology

Background:

• Choroidal neovascularization (CNV) is a key pathological process in exudative age-related macular degeneration (AMD), a major cause of vision loss.
• Inflammation is implicated as a risk factor for AMD development.
• The IKK2/NF-κB pathway is central to inflammatory responses, regulating genes involved in inflammation and angiogenesis.

Purpose of the Study:

• To investigate the functional role of IKK2 in the development of laser-induced CNV.
• To explore the therapeutic potential of targeting the IKK2/NF-κB pathway for exudative AMD.

Main Methods:

• Utilized Ikk2 conditional knockout mice and a specific IKK2 chemical inhibitor (TPCA-1).
• Generated retinal and RPE-specific IKK2 deletion by breeding Ikk2(-/flox) mice with Nestin-Cre mice.
• Assessed CNV development in vivo and analyzed gene expression changes in ARPE-19 cells in vitro.

Main Results:

• Deletion of Ikk2 in the retina did not cause developmental or functional defects but significantly reduced laser-induced CNV.
• Both genetic deletion and pharmacological inhibition of IKK2 (TPCA-1) effectively suppressed CNV.
• Inhibition of IKK2 in vitro reduced the expression of key pro-inflammatory and pro-angiogenic factors (e.g., VEGFA, HIF1A, MMP-2).

Conclusions:

• The IKK2/NF-κB signaling pathway is crucial for the production of pro-inflammatory and pro-angiogenic factors in laser-induced CNV.
• Targeting IKK2/NF-κB signaling represents a promising therapeutic strategy for managing aberrant angiogenesis in exudative AMD.